Immunohistochemical evaluation of Ki-67 expression and apoptosis in cyclosporin A-induced gingival overgrowth

Journal of Periodontology

Volumn 78, Issue 2, 2007, Pages 282-289

  Buduneli, Nurcan ^a   Buduneli, Eralp ^a   Çinar, Sema ^a   Lappin, David ^b   Kinane, Denis F ^c  

^a EGE UNIVERSITY   (Turkey)

^b GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Apoptosis; Cell division; Gingival overgrowth pathogenesis; Immunohistochemistry; In situ hybridization; Ki 67 antigen

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; KI 67 ANTIGEN; NIFEDIPINE; PHENYTOIN;

ADULT; ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; FEMALE; GINGIVA OVERGROWTH; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MITOSIS; NICK END LABELING; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; ANALYSIS OF VARIANCE; APOPTOSIS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CYCLOSPORINE; FEMALE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; KI-67 ANTIGEN; KIDNEY TRANSPLANTATION; MALE; MITOSIS; NIFEDIPINE; PHENYTOIN; STATISTICS, NONPARAMETRIC;

EID: 33847783333     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060051     Document Type: Article

References (45)

1. Rateitschak-Plüss EM, Hefti A, Lörtscher R, Theil G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
2. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin-A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
3. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
4. Modeer T, Dahllof G, Otteskog P. The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro. Acta Odontol Scand 1982;40: 353-357.
5. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:311-314.
6. Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004;15:165-175.
7. Mariani G, Calastrini C, Carinci F, Marzola R, Calura G. Ultrastructural features of cyclosporin A-induced gingival hyperplasia. J Periodontol 1993;64:1092-1097.
8. Vardar S, Baylas H, Zihnioǧlu F, Buduneli N, Emingil G, Atilla G. Gingival tissue proteoglycan and chondroitin-4-sulphate levels in cyclosporin A-induced gingival overgrowth and the effects of initial periodontal treatment. J Clin Periodontol 2005;32:634-639.
9. Wondimu B, Reinholt FP, Modeer T. Stereologic study of cyclosporin A-induced gingival overgrowth in renal transplant patients. Eur J Oral Sci 1995;103:199-206.
10. Hassell TM. Phenytoin: Gingival overgrowth. In: Hassell TM, ed. Epilepsy and the Oral Manifestations of Phenytoin Therapy. Basel, Switzerland: S. Karger; 1981:116-137.
11. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
12. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
13. Atilla G, Kütükçüler N. Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A. J Periodontol 1998;69:784-790.
14. Buduneli N, Atilla G, Kütükçüler N. Are inflammatory cytokines potential mediators of phenytoin-induced gingival overgrowth? Turkish J Med Sci 2001;31:41-46.
15. Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth. J Periodontol 1994;65:895-903.
16. Buduneli N, Kütükçüler N, Aksu G, Atilla G. Evaluation of transforming growth factor-β1 level in crevicular fluid of cyclosporin A-treated patients. J Periodontol 2001;72:526-531.
17. Buduneli N, Saǧol Ö, Atilla G, Duman S, Holmstrup P. Immunohistochemical analysis of epidermal growth factor receptor in cyclosporine A-induced gingival overgrowth. Acta Odontol Scand 2001;59:367-371.
18. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
19. Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. J Periodontol 1996; 67:264-270.
20. Buduneli N, Buduneli E, Çinar S, Atilla G, Lappin D, Kinane D. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients. J Clin Periodontol 2004;31: 556-561.
21. Cohen J, Duke R. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267-293.
22. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
23. Gerdes J, Lemke M, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133: 1710-1715.
24. Bacchi CE, Gown AM. Detection of cell proliferation in tissue sections. Braz J Med Biol Res 1993;26:677-687.
25. Saxer UP, Mühlemann HR. Motivation and education (in German). SSO Schweiz Monatsschr Zahnheilkd 1975;85:905-919.
26. Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. J Clin Periodontol 1999;26:183-189.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119: 493-501.
28. Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-induced gingival overgrowth - A review. Biol Pharm Bull 2005;28:1817-1821.
29. Tonetti MS, Cortellini D, Lang NP. In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingiva. Infect Immun 1998;66: 5190-5195.
30. Rees TD. Drugs and oral disorders. Periodontol 2000 1998;18:21-36.
31. Thomas SE, Andoh TF, Pichler RH, et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998;53:897-908.
32. Buduneli E, Genel F, Atilla G, Kütükçüler N. Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients. J Periodontol 2003; 74:506-511.
33. Esposito C, Fornoni A, Cornacchia F, et al. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 2000;58:123-130.
34. Asai T, Nakatani T, Tamada S, et al. Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: Role in beneficial effects of magnesium supplementation. Transplantation 2003;75:1040-1044.
35. Bostrom A, Bharath H, Saulewicz A, Narayanan AS. Cyclosporin A affects signaling events differentially in human gingival fibroblasts. J Dent Res 2005;84:532-536.
36. Feske S, Okamura H, Hogan PG, Rao A. Ca2+/calcineurin signaling in cells of the immune system. Biochem Biophys Res Commun 2003;311:1117-1132.
37. Watanabe A, Takeshita A, Kitano Z, Hanazawa S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 1996;64:4488-4494.
38. Niimi A, Tohnai I, Kaneda T, Takeuchi M, Nagura M. Immunohistochemical analysis of effect of cyclosporine A on gingival epithelium. J Oral Pathol Med 1990; 19:397-403.
39. Shimizu Y, Kataoka M, Seto H, Kido J, Nagata T. Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis. J Periodontol 2002; 73:861-867.
40. Bulut ÖE, Sökmensüer LK, Bulut Ş, Tasman F, Müftüoǧlu S. Immunohistochemical study of cyclosporin-induced gingival overgrowth in renal transplant recipients. J Periodontol 2004;75:1655-1662.
41. Bulut Ş, Özdemir BH, Alaaddinoǧlu EE, Oduncuoǧlu FB, Bulut ÖE, Demirhan B. Effect of cyclosporin A on apoptosis and expression of p53 and bcl-2 proteins in the gingiva of renal transplant patients. J Periodontol 2005;76:691-695.
42. Zoeller J, Flentje M, Sinn P, Born IA. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasia and carcinomas. Anal Cell Pathol 1994;7:77-88.
43. Saito K, Mori S, Tanda N, Sakamoto S. Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol 1999;70:581-586.
44. Mesa F, Aguilar M, Gonzales-Moles MA, et al. Vigabatrin-induced modification of Ki-67 expression in gingival epithelium: Immunohistochemical study of a short series. J Periodontal Res 2004;39:66-71.
45. Nurmenniemi PK, Pernu HE, Knuuttila MLE. Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 2001;72:167-173.